论文部分内容阅读
卡培他滨(希罗达)是一种新的肿瘤内激活的口服氟尿嘧啶前体药物,2003年6月-2006年4月采用希罗达单药治疗晚期胃肠道肿瘤28例,取得了较好疗效。报告如下:1资料与方法1.1一般资料28例晚期胃肠道癌患者均经病理和(或)细胞学诊断,男18例,女10例,年龄60～75岁。Karnofsky评分≥50分
Capecitabine (Xeloda) is a novel intratumor activated oral fluorouracil prodrug, 28 cases of advanced gastrointestinal cancer treated with Xeloda monotherapy from June 2003 to April 2006, and obtained Good effect. The report is as follows: 1 Materials and Methods 1.1 General Information 28 cases of advanced gastrointestinal cancer patients were pathological and (or) cytological diagnosis, 18 males and 10 females, aged 60 to 75 years. Karnofsky score ≥50 points